The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
An integrated view of cisplatin-induced nephrotoxicity and ototoxicity
Open accessAbstract
Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and ototoxic side-effects remain major clinical limitations. Recent studies have improved our understanding of the molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. While cisplatin binding to DNA is the major cytotoxic mechanism in proliferating (cancer) cells, nephrotoxicity and ototoxicity appear to result from toxic levels of reactive oxygen species and protein dysregulation within various cellular compartments. In this review, we discuss molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. We also discuss potential clinical strategies to prevent nephrotoxicity and ototoxicity and their current limitations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The capsaicin receptor: a heat-activated ion channel in the pain pathway
Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. (1997) · Nature · doi:10.1038/39807 · Cited by 9,107
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Cisplatin Nephrotoxicity: A Review
Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31812dfe1e · Cited by 1,251
Shen, D.-W., Pouliot, L. M., Hall, M. D., & Gottesman, M. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005637 · Cited by 955
Fuertes, M. A., Alonso, C., & Pérez, J. M. (2003) · Chemical Reviews · doi:10.1021/cr020010d · Cited by 893
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
Ramesh, G., & Reeves, W. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15606 · Cited by 866
Bess, F. H., Dodd-Murphy, J., & Parker, R. A. (1998) · Ear and Hearing · doi:10.1097/00003446-199810000-00001 · Cited by 847 · cited 2×
“Pediatric hearing loss delays educational attainment and psychosocial development (Bess et al., 1998; Knight et al., 2005).”
BackgroundBlocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
Popivanova, B. K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S., Oshima, M., Fujii, C., & Mukaida, N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32453 · Cited by 832
Marullo, R., Werner, E., Degtyareva, N., Moore, B., Altavilla, G., Ramalingam, S. S., & Doetsch, P. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081162 · Cited by 777
Hudspeth, A. J., & Corey, D. P. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.6.2407 · Cited by 769
Pickles, J. O., Comis, S. D., & Osborne, M. P. (1984) · Hearing Research · doi:10.1016/0378-5955(84)90041-8 · Cited by 702
Platinum neurotoxicity pharmacogenetics
McWhinney, S. R., Goldberg, R. M., & McLeod, H. L. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0840 · Cited by 574
Mechanisms of cisplatin-induced ototoxicity and prevention
Rybak, L. P., Whitworth, C. A., Mukherjea, D., & Ramkumar, V. (2007) · Hearing Research · doi:10.1016/j.heares.2006.09.015 · Cited by 563
Knight, K. R. G., Kraemer, D. F., & Neuwelt, E. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5355 · Cited by 542
Hensley, M. L., Hagerty, K. L., Kewalramani, T., Green, D. M., Meropol, N. J., Wasserman, T. H., Cohen, G. I., Emami, B., Gradishar, W. J., Mitchell, R. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2627 · Cited by 540
Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade
Juo, P., Kuo, C. J., Yuan, J., & Blenis, J. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00420-4 · Cited by 526
Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., Litwack, G., & Alnemri, E. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14486 · Cited by 520
Tip-link integrity and mechanical transduction in vertebrate hair cells
Assad, J. A., Shepherd, G. M. G., & Corey, D. P. (1991) · Neuron · doi:10.1016/0896-6273(91)90343-x · Cited by 505
Knox, R. J., Friedlos, F., Lydall, D. A., & Roberts, J. J. (1986) · PubMed · Cited by 498
Nox3, a superoxide-generating nadph oxidase of the inner ear
Bánfi, B., Malgrange, B., Knisz, J., Steger, K., Dubois-Dauphin, M., & Krause, K.-H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403046200 · Cited by 467
Ciarimboli, G., Deuster, D., Knief, A., Sperling, M., Holtkamp, M., Edemir, B., Pavenstädt, H., Lanvers-Kaminsky, C., am Zehnhoff-Dinnesen, A., Schinkel, A. H., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090610 · Cited by 444
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury
Deng, J., Kohda, Y., Chiao, H., Wang, Y., Hu, X., Hewitt, S. M., Miyaji, T., Mcleroy, P., Nibhanupudy, B., Li, S., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00043.x · Cited by 399
Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
Filipski, K. K., Mathijssen, R. H., Mikkelsen, T. S., Schinkel, A. H., & Sparreboom, A. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.139 · Cited by 399
Faubel, S., Lewis, E. C., Reznikov, L., Ljubanovic, D., Hoke, T. S., Somerset, H., Oh, D.-J., Lu, L., Klein, C. L., Dinarello, C. A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119792 · Cited by 399
THE SOCIETAL COSTS OF SEVERE TO PROFOUND HEARING LOSS IN THE UNITED STATES
Mohr, P. E., Feldman, J. J., Dunbar, J. L., McConkey-Robbins, A., Niparko, J. K., Rittenhouse, R. K., & Skinner, M. W. (2000) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300103162 · Cited by 398
Curing metastatic testicular cancer
Einhorn, L. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072067999 · Cited by 387
Brock, P. R., Knight, K. R., Freyer, D. R., Campbell, K. C. M., Steyger, P. S., Blakley, B. W., Rassekh, S. R., Chang, K. W., Fligor, B. J., Rajput, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.1110 · Cited by 380
Self-citationCisplatin Ototoxicity and Protection: Clinical and Experimental Studies
Rybak, L. P., Mukherjea, D., Jajoo, S., & Ramkumar, V. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.219.177 · Cited by 372
Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent Pathways
Cummings, B. S., & Schnellmann, R. G. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.8 · Cited by 358
Hypomagnesemia and Renal Magnesium Wasting in Patients Receiving Cisplatin
SCHILSKY, R. L., & ANDERSON, T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-6-929 · Cited by 344
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer
Bokemeyer, C., Berger, C., Hartmann, J., Kollmannsberger, C., Schmoll, H., Kuczyk, M., & Kanz, L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.226 · Cited by 339
siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury
Molitoris, B. A., Dagher, P. C., Sandoval, R. M., Campos, S. B., Ashush, H., Fridman, E., Brafman, A., Faerman, A., Atkinson, S. J., Thompson, J. D., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111204 · Cited by 337
Marcotti, W., van Netten, S. M., & Kros, C. J. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.085951 · Cited by 331
the CPNDS Consortium, Ross, C. J. D., Katzov-Eckert, H., Dubé, M.-P., Brooks, B., Rassekh, S. R., Barhdadi, A., Feroz-Zada, Y., Visscher, H., Brown, A. M. K., et al. (2009) · Nature Genetics · doi:10.1038/ng.478 · Cited by 327
Kruidering, M., Van De Water, B., De Heer, E., Mulder, G. J., & Nagelkerke, J. F. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36493-6 · Cited by 325
Zhang, B., Ramesh, G., Norbury, C. C., & Reeves, W. B. (2007) · Kidney International · doi:10.1038/sj.ki.5002242 · Cited by 309
Henson, E. S., & Gibson, S. B. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.015 · Cited by 300
Rybak, L. P., & Ramkumar, V. (2007) · Kidney International · doi:10.1038/sj.ki.5002434 · Cited by 298
Pabla, N., Murphy, R. F., Liu, K., & Dong, Z. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90545.2008 · Cited by 283
Roles of NADPH Oxidases in Cisplatin-Induced Reactive Oxygen Species Generation and Ototoxicity
Kim, H.-J., Lee, J.-H., Kim, S.-J., Oh, G. S., Moon, H.-D., Kwon, K.-B., Park, C., Park, B. H., Lee, H.-K., Chung, S.-Y., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6054-09.2010 · Cited by 280
Cisplatin Induces Apoptosis in LLC-PK1 Cells via Activation of Mitochondrial Pathways
Park, M. S., De Leon, M., & Devarajan, P. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134858 · Cited by 279
Nephrotoxicity and Hydration Management for Cisplatin, Carboplatin, and Ormaplatin
Cornelison, T. L., & Reed, E. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1184 · Cited by 270
de Jongh, F. E., van Veen, R. N., Veltman, S. J., de Wit, R., van der Burg, M. E. L., van den Bent, M. J., Planting, A. S. T., Graveland, W. J., Stoter, G., & Verweij, J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600884 · Cited by 269
Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells
Yang, C., Kaushal, V., Shah, S. V., & Kaushal, G. P. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00590.2007 · Cited by 268
p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice
Ramesh, G., & Reeves, W. B. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00401.2004 · Cited by 267
Preclinical studies identifying carboplatin as a viable cisplatin alternative
Harrap, K. R. (1985) · Cancer Treatment Reviews · doi:10.1016/0305-7372(85)90015-5 · Cited by 259
Tsuruya, K., Ninomiya, T., Tokumoto, M., Hirakawa, M., Masutani, K., Taniguchi, M., Fukuda, K., Kanai, H., Kishihara, K., Hirakata, H., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00709.x · Cited by 241
d-Methionine provides excellent protection from cisplatin ototoxicity in the rat
Campbell, K. C. M., Rybak, L. P., Meech, R. P., & Hughes, L. (1996) · Hearing Research · doi:10.1016/s0378-5955(96)00152-9 · Cited by 240
Advanced Ovarian Cancer Trialists' Group, Aabo, K., Adams, M., Adnitt, P., Alberts, D., Athanazziou, A., Barley, V, Bell, D., Bianchi, U., Bolis, G., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.710 · Cited by 234
Activation and involvement of p53 in cisplatin-induced nephrotoxicity
Wei, Q., Dong, G., Yang, T., Megyesi, J., Price, P. M., & Dong, Z. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00230.2007 · Cited by 232
So, H., Kim, H., Lee, J.-H., Park, C., Kim, Y., Kim, E., Kim, J.-K., Yun, K.-J., Lee, K.-M., Lee, H.-Y., et al. (2007) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-007-0084-9 · Cited by 230
Mukhopadhyay, P., Rajesh, M., Pan, H., Patel, V., Mukhopadhyay, B., Bátkai, S., Gao, B., Haskó, G., & Pacher, P. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.022 · Cited by 220
Dickey, D. T., Wu, Y. J., Muldoon, L. L., & Neuwelt, E. A. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087601 · Cited by 219
Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells
Arany, I., Megyesi, J. K., Kaneto, H., Price, P. M., & Safirstein, R. L. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00112.2004 · Cited by 215
Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis
Jiang, M., Wei, Q., Wang, J., Du, Q., Yu, J., Zhang, L., & Dong, Z. (2006) · Oncogene · doi:10.1038/sj.onc.1209440 · Cited by 209
Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways
Devarajan, P., Savoca, M., Castaneda, M. P., Park, M. S., Esteban-Cruciani, N., Kalinec, G., & Kalinec, F. (2002) · Hearing Research · doi:10.1016/s0378-5955(02)00634-2 · Cited by 204
Wang, J., Ladrech, S., Pujol, R., Brabet, P., Van De Water, T. R., & Puel, J.-L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1581 · Cited by 203
Faubel, S., Ljubanovic, D., Reznikov, L., Somerset, H., Dinarello, C. A., & Edelstein, C. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66010.x · Cited by 196
Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent
Wisnovsky, S. P., Wilson, J. J., Radford, R. J., Pereira, M. P., Chan, M. R., Laposa, R. R., Lippard, S. J., & Kelley, S. O. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.08.010 · Cited by 185
Endoplasmic Reticulum Stress–Associated Caspase 12 Mediates Cisplatin-Induced LLC-PK1 Cell Apoptosis
Liu, H., & Baliga, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090768 · Cited by 182
Role of the Copper Transporter, CTR1, in Platinum-Induced Ototoxicity
More, S. S., Akil, O., Ianculescu, A. G., Geier, E. G., Lustig, L. R., & Giacomini, K. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1544-10.2010 · Cited by 176
Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity
Jiang, M., Yi, X., Hsu, S., Wang, C.-Y., & Dong, Z. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00262.2004 · Cited by 175
Seth, R., Yang, C., Kaushal, V., Shah, S. V., & Kaushal, G. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503305200 · Cited by 173
Liu, H., & Baliga, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00908.x · Cited by 171
p53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells
Zamble, D. B., Jacks, T., & Lippard, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6163 · Cited by 169
Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro
Clerici, W. J., DiMartino, D. L., & Prasad, M. R. (1995) · Hearing Research · doi:10.1016/0378-5955(95)00010-2 · Cited by 164
Probing the pore of the auditory hair cell mechanotransducer channel in turtle
Farris, H. E., LeBlanc, C. L., Goswami, J., & Ricci, A. J. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.061267 · Cited by 161
Zhang, M., Liu, W., Ding, D., & Salvi, R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00286-0 · Cited by 157
Nucleotide Excision Repair Pathways Involved in Cisplatin Resistance in Non-Small-Cell Lung Cancer
Rosell, R., Tarón, M., Barnadas, A., et al. (2003) · Cancer Control · doi:10.1177/107327480301000404 · Cited by 156
Risk factors for cisplatin‐associated ototoxicity in pediatric oncology patients
Yancey, A. M., Harris, M. S., Egbelakin, A., Gilbert, J. L., Pisoni, D. B., & Renbarger, J. L. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24138 · Cited by 154
Lee, R. H., Song, J. M., Park, M. Y., Kang, S. K., Kim, Y. K., & Jung, J. S. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00748-1 · Cited by 150
Kaur, T., Mukherjea, D., Sheehan, K. E., Jajoo, S., Rybak, L. P., & Ramkumar, V. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.63 · Cited by 148
Mukherjea, D., Jajoo, S., Whitworth, C. A., Bunch, J. R., Turner, J. G., Rybak, L. P., & Ramkumar, V. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1307-08.2008 · Cited by 147
Caronia, D., Patiño‐García, A., Milne, R. L., Zalacaín, M., Pita, G., Alonso, M. R., Moreno, L. T., Sierrasesúmaga-Ariznabarreta, L., Benitez, J. J., & González‐Neira, A. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.19 · Cited by 144
Mukherjea, D., Jajoo, S., Kaur, T., Sheehan, K. E., Ramkumar, V., & Rybak, L. P. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3110 · Cited by 144
HSP90 regulates cell survival via inositol hexakisphosphate kinase-2
Chakraborty, A., Koldobskiy, M. A., Sixt, K. M., Juluri, K. R., Mustafa, A. K., Snowman, A. M., van Rossum, D. B., Patterson, R. L., & Snyder, S. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711168105 · Cited by 135
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss
Xu, H., Robinson, G. W., Huang, J., Lim, J. Y.-S., Zhang, H., Bass, J. K., Broniscer, A., Chintagumpala, M., Bartels, U. K., Gururangan, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3217 · Cited by 135
Protection of renal cells from cisplatin toxicity by cell cycle inhibitors
Price, P. M., Safirstein, R. L., & Megyesi, J. K. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00192.2003 · Cited by 134
Kidera, Y., Kawakami, H., Sakiyama, T., Okamoto, K., Tanaka, K., Takeda, M., Kaneda, H., Nishina, S., Tsurutani, J., Fujiwara, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101902 · Cited by 131
Polymorphisms in ERCC1 and Grade 3 or 4 Toxicity in Non–Small Cell Lung Cancer Patients
Suk, R. N., Gurubhagavatula, S., Park, S., Zhou, W., Li, S., Lynch, T. J., Wain, J. C., Neuberg, D. S., Liu, G., & Christiani, D. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1953 · Cited by 128
Lu, L., Oh, D., Dursun, B., He, Z., Hoke, T. S., Faubel, S. G., & Edelstein, C. L. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130161 · Cited by 117
Cisplatin dose rate as a risk factor for nephrotoxicity in children
Skinner, R., Pearson, A. D. J., English, M., Price, L., Wyllie, R., Coulthard, M., & Craft, A. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.276 · Cited by 112
Endotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity
Koo, J., Quintanilla‐Dieck, L., Jiang, M., Liu, J., Urdang, Z. D., Allensworth, J. J., Cross, C. P., Hong-zhe, L., & Steyger, P. S. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac5546 · Cited by 111
Self-citationModelling the encapsulation of the anticancer drug cisplatin into carbon nanotubes
Hilder, T. A., & Hill, J. M. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/27/275704 · Cited by 110
Li, G., Frenz, D. A., Brahmblatt, S., Feghali, J. G., Ruben, R. J., Berggren, D., Arezzo, J. C., & Water, T. R. V. D. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(00)00010-3 · Cited by 109
Cisplatin-Induced Hair Cell Death Requires STAT1 and Is Attenuated by Epigallocatechin Gallate
Schmitt, N. C., Rubel, E. W., & Nathanson, N. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5842-08.2009 · Cited by 101
Thomas, A. J., Hailey, D. W., Stawicki, T. M., Wu, P., Coffin, A. B., Rubel, E. W., Raible, D. W., Simon, J. A., & Ou, H. C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3940-12.2013 · Cited by 101
Mukherjea, D., Jajoo, S., Sheehan, K. E., Kaur, T., Sheth, S., Bunch, J. R., Perro, C. A., Rybak, L. P., & Ramkumar, V. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3497 · Cited by 98
Mechanisms of Epithelial Repair and Regeneration After Acute Kidney Injury
Berger, K., & Moeller, M. J. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.06.006 · Cited by 94
Effect of JNK inhibition on cisplatin-induced renal damage
Francescato, H. D. C., Costa, R. S., Junior, F. B., & Coimbra, T. M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm144 · Cited by 91
Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity
Mishima, K., Baba, A., Matsuo, M., Itoh, Y., & Oishi, R. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.025 · Cited by 90
Carleton, B., Poole, R., Smith, M., et al. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1772 · Cited by 84
Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin
Mukherjea, D., Whitworth, C. A., Nandish, S., Dunaway, G., Rybak, L. P., & Ramkumar, V. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.044 · Cited by 83
Sprowl, J. A., van Doorn, L., Hu, S., van Gerven, L., de Bruijn, P., Li, L., Gibson, A. A., Mathijssen, R. H. J., & Sparreboom, A. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.145 · Cited by 83
Oh, G., Kim, H., Choi, J.-H., Shen, A., Kim, C.-H., Kim, S., Shin, S., Hong, S., Kim, Y., Park, C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002183 · Cited by 79
Identification of Cisplatin-Binding Proteins Using Agarose Conjugates of Platinum Compounds
Karasawa, T., Sibrian‐Vazquez, M., Strongin, R. M., & Steyger, P. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066220 · Cited by 71
Self-citationYu, F. H. Z., Megyesi, J. K., Safirstein, R. L., & Price, P. M. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2005 · Cited by 71
Sound preconditioning therapy inhibits ototoxic hearing loss in mice
Roy, S., Ryals, M. M., van den Bruele, A. B., Fitzgerald, T. S., & Cunningham, L. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71353 · Cited by 71
AAV-Mediated Delivery of the Caspase Inhibitor XIAP Protects Against Cisplatin Ototoxicity
Cooper, L. B., Chan, D. K., Roediger, F. C., Shaffer, B. R., Fraser, J. F., Musatov, S. A., Selesnick, S. H., & Kaplitt, M. G. (2006) · Otology & Neurotology · doi:10.1097/01.mao.0000202647.19355.6a · Cited by 71
The design and screening of drugs to prevent acquired sensorineural hearing loss
Mukherjea, D., Rybak, L. P., Sheehan, K. E., Kaur, T., Ramkumar, V., Jajoo, S., & Sheth, S. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.562887 · Cited by 68
Ikeda, K., Sunose, H., & Takasaka, T. (1993) · Acta Oto-Laryngologica · doi:10.3109/00016489309135781 · Cited by 67
Faivre, S. J., Kalla, S., Cvitkovic, E., Bourdon, O., Hauteville, D., Dourte, L. M., Bensmaïne, M. A., Itzhaki, M., Marty, M. E., & Extra, J.-M. (1999) · Annals of Oncology · doi:10.1023/a:1008334215414 · Cited by 65
Harned, T. M., Kalous, O., Neuwelt, A. J., Loera, J., Ji, L., Iovine, P. M., Sposto, R., Neuwelt, E. A., & Reynolds, C. P. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2289 · Cited by 65
Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs
van Ruijven, M. W. M., de Groot, J. C. M. J., Hendriksen, F. G. J., & Smoorenburg, G. F. (2005) · Hearing Research · doi:10.1016/j.heares.2004.12.007 · Cited by 58
Cisplatin ototoxicity to the rat inner ear: A role for HMG1 and iNOS
Li, G., Liu, W., & Frenz, D. A. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.05.010 · Cited by 55
Jamesdaniel, S., Coling, D., Hinduja, S., Ding, D., Li, J., Cassidy, L., Seigel, G. M., Qu, J., & Salvi, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297960 · Cited by 53
Update on the diagnosis and management of acute kidney injury
Edelstein, C. (2010) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s8641 · Cited by 52
Boersma, A. W. M., Nooter, K., Burger, H., Kortland, C. J., & Stoter, G. (1997) · Cytometry · Cited by 51
Guthrie, O. W., Li‐Korotky, H., Durrant, J. D., & Balaban, C. D. (2008) · Hearing Research · doi:10.1016/j.heares.2008.01.013 · Cited by 36
Cisplatin exposure damages resident stem cells of the mammalian inner Ear
Slattery, E. L., Oshima, K., Heller, S., & Warchol, M. E. (2014) · Developmental Dynamics · doi:10.1002/dvdy.24150 · Cited by 32
The combined effect of cisplatin and furosemide on hearing function in guinea pigs
Laurell, G. F. E., & Engström, B. (1989) · Hearing Research · doi:10.1016/0378-5955(89)90124-x · Cited by 31
Cardinaal, R. M., de Groot, J. C. M. J., Huizing, E. H., Veldman, J. E., & Smoorenburg, G. F. (2000) · Hearing Research · doi:10.1016/s0378-5955(00)00061-7 · Cited by 25
Immunohistochemical localization of OCT2 in the cochlea of various species
Hellberg, V., Gahm, C., Liu, W., Ehrsson, H., Rask‐Andersen, H., & Laurell, G. F. E. (2015) · The Laryngoscope · doi:10.1002/lary.25304 · Cited by 20
Lu, X., Wang, L., & Ruden, D. M. (2012) · Pharmaceuticals · doi:10.3390/ph5090890 · Cited by 12
Cited by
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010197 · Cited by 1,525
The rediscovery of platinum-based cancer therapy
Rottenberg, S., Disler, C., & Perego, P. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00308-y · Cited by 972
Cisplatin is retained in the cochlea indefinitely following chemotherapy
Breglio, A. M., Rusheen, A. E., Shide, E. D., Fernandez, K. A., Spielbauer, K. K., McLachlin, K. M., Hall, M. D., Amable, L., & Cunningham, L. L. (2017) · Nature Communications · doi:10.1038/s41467-017-01837-1 · Cited by 412
Molecular imaging and disease theranostics with renal-clearable optical agents
Cheng, P., & Pu, K. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00328-6 · Cited by 413
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
Lee, S. Y., Kim, C. Y., & Nam, T.-G. (2020) · Drug Design, Development and Therapy · doi:10.2147/dddt.s275007 · Cited by 400
Metadata
- Authors
- Karasawa, T., & Steyger, P. S.
- Venue
- Toxicology Letters
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 237
- Issue
- 3
- Pages
- 219-227
- ISSN
- 0378-4274 (ISSN-L)
- OpenAlex
- W927594411
- Cited by
- 475
- References
- 118
- FWCI
- 23.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.